Share

Videos

Why the FDA cracked down on 23andMe

The Washington Post
|
December 19, 2013 AT 6:18 PM
Dr. Robert Klitzman, of Columbia University's Masters in Bioethics Program, discusses the stiff backlash that direct-to-consumer genetic testing firm 23andMe recently faced from the FDA.